Response
We appreciate Dr Stabile's interest in our article and the opportunity to respond to his letter. Calcium channel blockade has been shown in several studies to prevent the shortening of atrial refractoriness that occurs during atrial fibrillation. In the study published by De Simone et al, 1 patients treated with verapamil plus propafenone had a lower rate of recurrence within 3 months (33 versus 8%). Other important studies, like that published by Van Noord et al, 2 had disappointing results. In that particular study, all other antiarrhythmic drugs were omitted, except for ␤-adrenergic blockers. In our study, different combinations of drugs and the higher use of ␤-adrenergic blockers together with calcium-channel blockers in the group of patients treated with irbesartan (24%) compared with the amiodarone group (12%) may have had a role in the potential benefit of irbesartan. However, there are other possible mechanisms; these include decrease of wall stress, modulation of refractoriness, interference with ion currents, modification of sympathetic tone, stabilization of electrolyte concentrations, and possible effects on transmembrane action potentials and currents. 3 Although electrical changes may be present after conversion of atrial fibrillation (which could be ameliorated with verapamil), the effect of structural changes may predominate (these could be modified with irbesartan). Efforts to reduce the structural changes that occur during atrial fibrillation may be more useful in preventing recurrences than efforts designed to minimize the electrical changes. Administration of irbesartan may have an antifibrotic effect due not only to its ability to diminish the synthesis of collagen type I, but also to its capacity to stimulate the degradation of collagen type I fibers. It may be important to intervene early, if possible, to prevent atrial structural remodeling before it occurs.
We agree with Dr Stabile that the pretreatment of patients with atrial fibrillation who undergo electrical cardioversion is important and will be the subject for continuous improvement.
